Skip to content

TAXAPHARM

Active Private limited companyfounded 2006active for 20 yearsDrève Richelle 161J, 1410 WaterlooKBO/BCE: BE 0879.817.912 subsidiary of

Lifetime

20 annual accounts with figures on one time axis
peak of €168,050 in 2011
-€35,928▼ €112,098
lowest -€77,453 in 2019
-€64,664▼ €51,543
peak of €53,251 in 2014
-€446,038▼ €64,664
€481,518▼ 5.2%
peak of 3.4 FTE in 2010
-not published
Board1 name since 2024
1 director
Owners
  
Documentsfilings and deeds
14-08-202614 days late
2025micro format
Gross margin from €76,170 to -€35,928Loss of €64,664Equity from -€381,374 to -€446,038Cash from €7,184 to €1,448

Key points

from the 2025 annual accounts

Equity

-€446,038
202020212022202320242025

Debts exceed assets in financial year 2025.

Losses

-€499,289 in eleven years
2015201620172018-77,453201920202021202220232024-64,6642025

Every financial year from 2015 to 2025 closed with a loss. 2019 was the heaviest.

Debts

€481,518 1,357% of the balance sheet
Financial debts 21%Suppliers 23%Taxes and wages 1%Other 55%

Of this, €400,893 falls due within a year.

Filings

20 annual accounts since 2006
AprilJune31 JulyOctober2010201520202025

Eight of the last ten came late. The 2018 accounts came in latest, 86 days after the end of the period.

Position in the sector

-1257.2%

Lower solvency than 95% of companies in retail trade. The sector median is 33.2%, over 25,428 companies.

Turnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,632 companies had the same profile as TAXAPHARM has now. Each dot stands for 17 companies, two years later.

84.3%
were still trading
10.2%
stopped another way
4.8%
went bankrupt
  • Micro
  • 20 years or older
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.6% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,632 companies, not a prediction for TAXAPHARM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • consolidatesannual accounts 2017
Board & ownership

Recent changes

Registered office moved from Charleroi to Waterloo - Drève Richelle The registered office moved from Rue de Gilly 173, 6010 Charleroi to 1410 Waterloo - Drève Richelle 161J boite 36 · Board meeting of 15-06-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0879817912
appointed as director Gazette deed
Registered office moved from Gilly to Couillet The registered office moved from CHAUSSEE IMPERIALE 34-6060 GILLY (CHARLEROI) to Rue de Gilly, 173 à 6010 Couillet · General meeting of 30-06-2022 · Gazette deed
All 37 events

Comparable companies

same main activity, similar in size and age
Company
TAXAPHARM Waterloo €35,480 -€35,928 -1257.2% -
DERMOCONCEPT Ghent €38,431 -€9,618 -131.4% -
DYNADERM Wavre €47,613 -€4,105 46.3% -
ESPACE MEDICAL JUMET Charleroi €29,613 -€4,699 -109.2% -
AJAGA Knokke-Heist €21,992 -€1,109 42.6% -
APOTHEEK A. JANSSENS Maasmechelen €55,793 €1,395 73.2% -
MIEKE DE GEETER Kortrijk €58,191 -€6,653 77.4% -

These companies have the same main activity as TAXAPHARM: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €22,000 and €58,200, founded between 2002 and 2013.

Official details

Source: KBO
Status
Active since 08-03-2006Normal situation
Registered office
33 active companies are registered at this addressOf these, 1 started in the 12 months before 22 November 2026. Source: KBO register, as of 22 November 2026.
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.152.218.7766010 Charleroi, since 15-03-2006
Financial year end
31 December
Peppol
Reachable since 27-02-2026
Company details

Annual accounts 2025

€35,480▼ 71.9%
Filing
Filed on 14-08-2026
Financials

Insights on TAXAPHARM

TAXAPHARM files the micro format. That format states no turnover. The gross margin fell from €48,653 in 2006 to -€35,928 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about TAXAPHARM

What is the company number of TAXAPHARM?
The company number of TAXAPHARM is 0879.817.912. The VAT number is the same number with BE in front: BE 0879.817.912.
Where is TAXAPHARM based?
The registered office is at Drève Richelle 161J, 1410 Waterloo.Company details
What does TAXAPHARM do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of TAXAPHARM?
TAXAPHARM is a private limited company (BV).
When was TAXAPHARM founded?
TAXAPHARM was founded on 08-03-2006.
Is TAXAPHARM still active?
Yes, TAXAPHARM is an active enterprise in the KBO register.
How many employees does TAXAPHARM have?
TAXAPHARM had an average of 0.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does TAXAPHARM fall under?
In its 2025 annual accounts, TAXAPHARM states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of TAXAPHARM?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.
Is TAXAPHARM profitable?
In financial year 2025, TAXAPHARM made a loss of €64,664.
Where can I find the annual accounts of TAXAPHARM?
TAXAPHARM filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of TAXAPHARM due?
TAXAPHARM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.